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Cleavage of BID by Caspase 8 Mediates
the Mitochondrial Damage in the Fas
Pathway of Apoptosis
membrane, mitochondrial depolarization, and the re-
lease of cytochrome c (Liu et al., 1996; Vander Heiden
et al., 1997). The release of cytochrome c may trigger
the interaction of Apaf1, a mammalian CED-4 homolog,
and Casp9, which in turn results in the activation of
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Casp9 (Li et al., 1997c; Zou et al., 1997). Activated Casp9
then cleaves and activates pro-Casp3, an event thatSummary
leads to the cleavage of other death substrates, cellular
and nuclear morphological changes, and ultimately, cellWe report here that BID, a BH3 domain±containing
death. An active site mutant of Casp9 (C287A) is ableproapoptotic Bcl2 family member, is a specific proxi-
to block activation of Casp3 by Casp9 (Li et al., 1997c).mal substrate of Casp8 in the Fas apoptotic signaling
Overexpression of Bcl2/BclxL has been shown to blockpathway. While full-length BID is localized in cytosol,
all apoptosis-induced mitochondrial changes (Kluck ettruncated BID (tBID) translocates to mitochondria and
al., 1997; Vander Heiden et al., 1997; Yang et al., 1997).thus transduces apoptotic signals from cytoplasmic
Since mitochondrial damage is an obligatory step inmembrane to mitochondria. tBID induces first the
mediating the Fas signaling in type II but not type I cells,clustering of mitochondria around the nuclei and re-
Bcl2/BclxL can inhibit Fas-induced apoptosis in type IIlease of cytochrome c independent of caspase activ-
but not type I cells (Scaffidi et al., 1998).ity, and then the loss of mitochondrial membrane po-
Bcl2 and BclxL, two members of the Bcl2 family, pre-tential, cell shrinkage, and nuclear condensation in
vent apoptosis induced by a variety of death stimulia caspase-dependent fashion. Coexpression of BclxL
(Merry and Korsmeyer, 1997). They are localized mainlyinhibits all the apoptotic changes induced by tBID. Our
to the outer mitochondrial, nuclear membranes and en-results indicate that BID is a mediator of mitochondrial
doplasmic reticular membrane through their carboxy-damage induced by Casp8.
terminal membrane anchorage domains. Both of them
contain the Bcl2 homology domains designated BH1,Introduction
BH2, BH3, and BH4, all of which are essential for the
antiapoptotic activity of Bcl2/BclxL (Merry and Kors-Caspase 8 (Casp8), a member of a mammalian caspase
meyer, 1997; Huang et al., 1998). The Bcl2 family alsofamily, has been demonstrated to play a key role in
includes a class of BH3 domain±containing death ago-mediating Fas-induced apoptosis (Boldin et al., 1996;
nists, which may promote apoptosis by inhibiting theFernandes-Alnemri et al., 1996; Muzio et al., 1996; Cryns
death antagonist members of the Bcl2 family (Merry andand Yuan, 1998). Cross-linking of the Fas receptor by
Korsmeyer, 1997). Mutational analyses indicate that theengagement of the Fas ligand or agonistic antibodies
BH3 domain of death agonists is required for their pro-results in the formation of so-called death-inducing sig-
apoptotic activity and their interactions with Bcl2/BclxLnal complex (DISC), which includes adaptor protein
(Chittenden et al., 1995; Wang et al., 1996; Kelekar et
FADD/MORT-1 and Casp8 (Kischkel et al., 1995). The
al., 1997). It was recently reported that in a cell-free
formation of the DISC leads to the activation of Casp8,
Xenopus oocyte system, the BH3 domain alone can
an initiator of the downstream apoptotic process that
induce cytochrome c release and the activation of cas-
includes the activation of Casp3, 26, and 27 and mito-
pases that can be inhibited by Bcl2 (Cosulich et al.,
chondrial damage (Salvesen and Dixit, 1997). Recently,
1997). Thus, these BH3-containing death agonists may
Scaffidi et al. (1998) have shown that there may be two play an important regulatory role in mediating apoptotic
alternative Fas signaling pathways. In so-called Fas type
mitochondrial damage. It is not clear, however, how
I cells, a relatively large amount of Casp8 is recruited to
these BH3 domain±containing proteins fit into the signal
DISC upon receptor cross-linking. The activated Casp8
transduction pathway of apoptosis and how they act to
propagates the apoptotic signal by activating down- induce mitochondrial damage.
stream caspases through proteolytic cleavage, as well In thisstudy, we demonstrate that BID, a death agonist
as by triggering mitochondrial damages that in turn acti- member of the Bcl2/BclxL family (Wang et al., 1996), is a
vate a proteolytic cascade. In so-called Fas type II cells, specific proximal substrate of Casp8 in the Fas signaling
a small amount of Casp8 is recruited to the DISC upon pathway. Cleavage of BID by Casp8 releases its potent
receptor cross-linking, and activated Casp8 mediates proapoptotic activity, which in turn induces mitochon-
downstream apoptotic events mainly through inducing drial damage and, ultimately, cell shrinkage and nuclear
mitochondrial damage. These studies, however, did not condensation.Expressionof BclxL inhibitsall the apoptotic
reveal how active Casp8 induces mitochondrial damage. phenotypes induced by truncated BID (tBID), whereas
A critical role of mitochondria in mediating apoptotic caspase inhibitors inhibit the loss of mitochondrial mem-
signal transduction pathway has been demonstrated re- brane potential, cell shrinkage, and nuclear condensa-
cently (Vander Heiden et al., 1997). Biochemical and tion, but not mitochondrial clustering and cytochrome
structural changes of mitochondria in apoptosis include c release. Our study identified the first specific proximal
mitochondrial swelling, disruption of mitochondrial outer substrate of Casp8 in the Fas pathway and a critical
missing link between the activation of Casp8 and mito-
chondrial damage.*To whom correspondence should be addressed.
Cell
492
Results
BID Is a Specific Substrate of Caspase 8 In Vitro
To identify the substrates of Casp8, we transcribed and
translated in vitro a small pool mouse spleen cDNA li-
brary in the presence of 35S-methionine, using the meth-
ods of Lustig et al. (1997). The radioactively labeled
protein pools were incubated with either recombinant
Casp8 in bacterial lysates or control lysates and ana-
lyzed by SDS-PAGE. cDNA small pools (1700) were
screened, and the individual cDNA clones containing
candidate Casp8 substrates were isolated from positive
pools. In pool #814, a 24 kDa protein disappeared after
incubation with Casp8 (Figure 1A). This pool was subdi-
vided, and the cDNA encoding this 24 kDa protein was
isolated and sequenced. The 24 kDa protein was identi-
fied to be murine BID, a proapoptotic Bcl2 family mem-
ber whose homology to other members of the family is
limited to a BH3 domain (Wang et al., 1996). N-terminal
T7-tagged BID was cleaved by Casp8 into 15 kDa and
14 kDa fragments in vitro (due to the different contents
of methionine in these two fragments, the two 35S-Met-
labeled fragments did not appear to be stoichiometric)
(Figure 1B). As the majority of the caspase substrates
identified so far are the substrates of Casp3, we deter-
mined the specificity of BID cleavage by Casp3 and 28,
using PARP as a control. 35S-labeled proteins were incu-
bated with limited amounts of Casp3 and 28 for different
lengths of time, and the cleavage efficiencies were eval-
uated by SDS-PAGE. As shown in Figure 1B, Casp8
cleaved most of BID but very little of PARP in 15 min,
while the contrary was true for Casp3. This in vitro cleav-
age result indicates that BID is a much better substrate
of Casp8 than of Casp3.
BID Is Cleaved In Vivo during Fas- and
TNFa-Induced Apoptosis
To examine the cleavage of BID in vivo, we generated
Figure 1. BID Is a Preferred Substrate of Caspase 8 In Vitroa polyclonal antibody against human BID protein. Using
(A) Primary screening of caspase substrates by small pool in vitrothis antibody for Western blots, we found that when
expression cloning. Different pools of 35S-labeled proteins were in-Jurkat cells were induced to undergo apoptosis by anti-
cubated with bacterial lysates containing either no caspase (a),Fas antibody, BID was initially cleaved to a 15 kDa frag-
Casp2 (b), or Casp8 (c) for 2 hr at 378C. The reactions were termi-ment and further to a 13 kDa fragment. The cleavage nated and analyzed by 12% SDS-PAGE. An arrow points to a band,
event occurred in the early stage of apoptosis and was later identified as murine BID, that disappeared in the presence of
comparable to the time courses of Casp7, -8 activation Casp8.
(B) BID is a better substrate of Casp8 than of Casp3. 35S-labeledand PARP cleavage in Jurkat cells (Figure 2A). To rule
N-terminal T7-tagged BID was incubatedwith either Casp3or Casp8out the possibility that the 15 kDa and 13 kDa BID frag-
for indicated time periods, and the cleavage products wereanalyzedments are newly synthesized novel protein products
by 15% SDS-PAGE.
recognized by the BID antibody, we induced Jurkat cells
to undergo apoptosis in the presence of cycloheximide
(CHX), an inhibitor of protein synthesis, and anti-Fas
inhibitor of caspases (Figure 2B). To confirm the cleav-antibody. The cleavage patterns of BID, Casp7, 28, and
age of BID in vivo and to determine the approximatePARP were examined by immunoblotting. We found that
site of cleavage, we transiently transfected C-terminalthe appearance of the BID fragments was not altered
Flag-tagged murine BID into HeLa cells, which wereby the presence of CHX (data not shown). Thus, the
then treated by TNFa and CHX to induce the activation15 kDa and 13 kDa BID fragments are likely to be the
of Casp8 and apoptosis. A Western blot of the cell lysatecleavage products of full-length BID induced by apopto-
was blotted by anti-FLAG antibody (Figure 2C). A 16sis. The amount of the 15 kDa peptide was constant
kDa Flag-tagged peptide was present in the apoptoticduring the time course of apoptosis, possibly due to its
lysate and absent in the control lysate, confirming ourrapid conversion to the 13 kDa peptide and subsequent
in vivo cleavage data and suggesting that the cleavagedegradation. The cleavage of BID in Fas-induced apo-
ptosis was inhibitable by 100 mM of zVAD-fmk, a peptide site of BID is in the N-terminal portion of the protein.
Transducing Fas Signal by Casp8 Cleavage of BID
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Figure 2. BID Is Cleaved In Vivo during Fas-
and TNFa-Induced Apoptosis
(A) Time course ofBID cleavage in Fas-induced
apoptosis of Jurkat cells. The cell viability
was determined by MTT assay and shown at
the bottom of the figure.
(B) BID cleavage was inhibited with zVAD-
fmk. Jurkat cells were preincubated with 100
mM of zVAD-fmk for 30 min and then incu-
bated with anti-Fas antibody for 5 hr. Total
cell lysates were prepared and blotted with
anti-BID antibody. Arrows point to the full-
length BID (p24) and two cleavage products,
p15 and p13.
(C) C-terminal Flag-tagged BID was cleaved
in TNFa-induced apoptosis of HeLa cells.
Twenty-four hours after transient transfection
of BID-Flag, HeLa cells were treated with ei-
ther 1 mg/ml CHX alone (2) or 10 ng/ml TNFa
and1 mg/ ml CHX (1) for 4 hr. Totalcell lysates
were subjected to Western blotting using ei-
ther anti-Flag or anti-Casp8 antibodies. The
molecular weight standard is shown on the
left. A 16 kDa fragment is present specifically
in the apoptotic HeLa cells transfected with
BID-flag.
Determination of Cleavage Sites of BID its proapoptotic activity is enhanced by its cleavage.
Two potential caspase cleavage sites reside in the N-ter- We cotransfected a LacZ construct with either wild-type
minal portion of murine BID: 56Leu-Gln-Thr-Asp-Gly60 BID or its cleavage-defective mutants into HeLa cells
(LQTDG) and 72Ile-Glu-Pro-Asp-Ser76 (IEPDS) (the cor- and then treated the cells with TNFa and CHX for 4
responding sequences for human BID are 57LQTDG61 hr. The percentages of cell death expressing BID was
and 72IEADS76). They match perfectly with the preferred determined by X-Gal staining. While 4 hr treatment of
cleavage sites for Casp8 and granzyme B, respectively, TNFa and CHX induced 54% of LacZ-transfected cells
as determined by combinatorial peptide library screen- to die (LacZ-transfected control cells without treatment
ing (Thornberry et al., 1997). To confirm that they are showed 3.8% of cell death, and WT BID±transfected cells
indeed the cleavage sites for Casp8 and granzyme B, without treatment showed 9.3% of cell death), the same
we mutated the two Asp residues to Glu either individu- TNFa and CHX treatment induced 91.5% of WT and
ally or both (namely mutant D59E, D75E, and DM). As 92.2% of D75E BID±transfected cells to die, respec-
shown in Figure 3A, N-terminal T7-tagged wild-type BID tively. Thus, the expression of wild-type and D75E BID
was completely cleaved by Casp1, -8, and granzyme B, increased TNFa-induced cell death by 69.4% and 69.5%,
and partially cleavedby Casp2 and 23. D59EBID mutant respectively, as shown in Figure 3B. In contrast, trans-
was only cleaved by granzyme B, not by caspases, while fection of D59E and DM mutant BID had insignificant
D75E BID mutant was cleaved efficiently by caspases, effects on TNFa-induced HeLa cell death (12.5% and
but not by granzyme B, suggesting that D75 is the cleav- 5.9%, respectively). The expression of BID and its mu-
age site for granzyme B while D59 is the caspase cleav- tants in transfected HeLa cells after TNFa treatment was
age site. As expected, the double mutant BID (DM BID) also examined. Wild-type and D75E BID were cleaved
was cleaved by neither the caspases nor granzyme B. into a 16 kDa fragment, but D59E and DM BID were not
Two fragments of BID, a 15 kDa and a 14 kDa, were (Figure 3C). Thus, the proapoptotic activity of BID is
generated by caspase cleavage. The 14 kDa peptide was strongly dependent upon its cleavage by Casp8 at D59.
shifted to 13 kDa when a wild-type BID without N-ter-
minal tag was cleaved by Casp8 (data not shown), sug-
The Cleaved BID Is a Potentgesting that the 15 kDa peptide is the C-terminal part
Apoptosis-Inducing Agentof BID and the 14 kDa peptide is the N-terminal portion
Most of the death agonists in the Bcl2 family contain awith an anomalous mobility in SDS-PAGE. As an addi-
BH3 domain that is essential for their Bcl2 binding andtional proof, the cleavage of BID by granzyme B gener-
proapoptotic activity (Chittenden et al., 1995; Wang etated a smaller C-terminal fragment and a larger N-termi-
al., 1996; Kelekar et al., 1997) and capable of inducingnal fragment that overlapped each other on SDS-PAGE
caspase activation in a cell-free Xenopus oocyte system(Figure 3A).
(Cosulich et al., 1997). It is possible that once BID is
cleaved, the truncated portion containing the BH3 do-The Proapoptotic Activity of BID Strongly
main becomes lethal to cells. To investigate this possi-Depends upon Its Cleavage
bility, we transiently transfected the C-terminal portionBID was previously identified as a death agonist (Wang
et al., 1996). Thus, it is interesting to examine whether of BID (residue 60±195) (tBID) into Rat-1 fibroblast cells.
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Figure 3. Proapoptotic Activity of BID Strongly Depends upon Its
Cleavage
(A) Determination of cleavage sites of BID. 35S-labeled wild-type BID
or its mutants were incubated with either caspases or granzyme B
and analyzed by SDS-PAGE. BID was cleaved by caspases into two
fragments: the larger one (15 kDa) was the C-terminal fragment, and
the smaller one (14 kDa) was the N-terminal fragment. The cleavage
products of granzyme B overlapped each other. Figure 4. BID Acts Downstream of Casp8 and Upstream of BclxL in
(B) Wild-type BID and D75E mutant promoted TNFa-induced apo- Fas-Induced Apoptosis
ptosis of HeLa cells, while caspase cleavage±defective mutants
(A) tBID-induced apoptosis of Rat-1 cells. Rat-1 cells seeded in
(D59E and DM) did not. HeLa cells were transfected with either the 6-well plate were transfected with either 1 mg pcDNA-Bid or 0.25
expression constructs of Bid or its mutants with LacZ construct
mg pcDNA-tBid along with 1 mg LacZ construct. For different cell
overnight and treated with 10 ng/ml TNFa and 1 mg/ml CHX for 4 death inhibitors, 0.25 mg tBID was cotransfected with either 1 mg
hr. After fixation, X-Gal staining was performed, and the percentage BclxL, 1 mg Bcl2, or 1 mg CrmA-expressing constructs, along withof cell death was scored by cell morphology of blue cells (flat, well- 1 mg LacZ construct. zVAD- fmk (100 mM) was added half an hour
attached versus round blue cells) as before (Miura et al., 1993). before transfection of tBid was performed. After 8 hr transfection,
(C) Cleavage of wild-type BID and its mutants in vivo. HeLa cells cells were fixed and X-Gal stained, and cell death percentage was
were transfected with the expression constructsof Bid or its mutants scored by cell morphology of blue cells.
overnight and then treated with TNFa and CHX for 4 hr. The cell (B) Time course of BID cleavage in vivo. MCF7/Fas and MCF7/Fas/
lysates were blotted with anti-Flag antibody. Arrows point to the BclxL cells were incubated with anti-Fas monoclonal antibody 7C11full-length Flag-tagged BID (p25) and its cleavage product, p16.
(1:500) in the presence of 1 mg/ml CHX for different periods of time
as indicated. Total cell lysates were then subjected to Western
blotting analysis using antibodies against BID, Casp8, Casp7, and
PARP. Arrows point to p24 (full-length BID), p15 (cleaved BID), p55
(full-length Casp8), p18 (cleaved Casp8), p35 (full-length Casp7),As shown in Figure 4A, full-length BID could not induce
p20 (cleaved Casp7), p116 (full-length PARP), and p89 (cleavedapoptosis, while tBID induced apoptosis very rapidly
PARP).
and efficiently. tBID-induced cell death was inhibited
completely by BclxL and zVAD-fmk, partially by Bcl2,
but not at all by CrmA. This result suggests that the N BID Acts Downstream of Caspase 8 and Upstream
of BclxL in Fas-Induced Apoptosisterminus of BID has an inhibitory effect to its proapo-
ptotic activity, and its removal by caspase cleavage To examine whether BID is a specific proximal substrate
of Casp8 and whether it operates upstream of BclxL/yields tBID that is an effective inducer of downstream
apoptotic events. The apoptosis-inducing activity of Bcl2, we used MCF7/Fas and its BclxL stable cell lines.
It has been shown that in MCF7 cells, BclxL can preventtBID is completely inhibited by BclxL, suggesting that
BID may function upstream of BclxL/Bcl2. As CrmA can Fas- and TNFa-induced cell death and inhibit down-
stream caspase activation even though Casp8 is acti-inhibit Casp1 and Casp8, but not other caspases (Zhou
et al., 1997), the failure of CrmA to inhibit tBID-induced vated (Medema et al., 1998; Srinivasan et al., 1998). As
shown in Figure 4B, the cleavage profile of BID corre-apoptosis is consistent with the hypothesis that BID
acts downstream of Casp8. lated perfectly with the activation of Casp8, both of
Transducing Fas Signal by Casp8 Cleavage of BID
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Figure 5. Truncated BID Has a Stronger Af-
finity for BclxL than Its Precursor
(A) tBID was colocalized with BclxL. Con-
structs expressing BID-Flag or tBID-Flag fu-
sion proteins were transiently transfected
into HeLa/BclxL stable cells. Immunohisto-
chemistry was performed using anti-Flag an-
tibody M2 and anti-BclxL antibody.
(B) In vitro interactions betweenBID andBclxL
or Bax. 35S-labeled BID or its cleaved form
was incubated with either GST-BclxL or GST-
Bax bound to glutathione-agarose beads.
After 3 hr incubation and three washes, the
bound BID or tBID was analyzed by SDS-
PAGE and autoradiography.
(C) In vivo interactions between BID and
BclxL. Constructs expressing BID-Flag or
tBID-Flag were cotransfected with BclxL con-
struct into HEK 293T cells. BID-Flag or tBID-
Flag was immunoprecipitated by anti-Flag
M2 affinity gel in the presence of 0.25% non-
ionic detergent IGEPAL CA-630 and Western
blotted using anti-BclxL antibody and M2anti-
Flag antibody, respectively.
(D) In vitro interaction between BID and BclxL
in the absence of nonionic detergent. 35S-
labeled BID or tBID was incubated with GST-
BclxL in a binding buffer without any nonionic
detergent, and the bound BID or tBID was
subjected to SDS-PAGE and autoradiog-
raphy.
which were not altered by expression of BclxL. In con- the same as its precursor. When tBID was overexpressed
trast, the activation of Casp7 and the cleavage of PARP in HeLa/BclxL stable cells, tBID colocalized with BclxL
were delayed and partially inhibited by overexpression (Figure 5A), suggesting that BID is translocated from
of BclxL. This result strongly supports our hypothesis cytoplasm to the membrane compartments when cleaved
that BID is a specific proximal substrate of Casp8 during by Casp8. In contrast, the full-length BID was evenly
Fas-induced apoptosis that functions upstream of BclxL. distributed in every cellular compartment (Figure 5A).
As BID does not have a membrane anchorage domain,
one possible mechanism of translocation is that tBIDTruncated BID Has a Stronger Affinity for BclxL
has a stronger affinity to BclxL than its precursor. Tothan the Full-Length BID
test this hypothesis, we examined the interaction be-How does tBID induce apoptosis? It was proposed that
tween tBID and BclxL in vitro and in vivo. We incubatedBID, which localizes in cytoplasmic as well as in mem-
35S-labeled BID or tBID with GST-BclxL in vitro in thebrane fractions, acts as a ligand to Bcl2/BclxL and Bax
(Wang et al., 1996). We examined whether tBID behaves presence of 0.25% nonionic detergent IGEPAL CA-630,
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and the amount of bound BID or tBID was analyzed by began to fade in the periphery of the cells and became
clustered around nuclei forming a ring (data not shown).SDS-PAGE. As estimated by intensities of the corre-
sponding bands, tBID has approximately 10-fold higher As the apoptotic process proceeded, cells shrank and
nuclei began to condense and fragment, and both sig-affinity toward GST-BclxL fusion protein compared to its
full-length precursor (Figure 5B), while the interaction nals of mitotracker and cytochrome c immunostaining
became diffused, while immunostaining of COX VIc be-between tBID and GST-Bax was undetectable. To exam-
ine the interaction of BID with BclxL in vivo, we cotrans- came intensified around shrunk nuclei (Figure 6A). This
result suggests that tBID induces the clustering of mito-fected the C-terminal Flag-tagged BID or its truncated
form with BclxL into HEK 293T cells and immunoprecipi- chondria, release of cytochrome c, loss of mitochondrial
membrane potential, cell shrinkage, and nuclear con-tated with anti-Flag M2 affinity gel in the presence of
0.25% nonionic detergent IGEPAL CA-630. The expres- densation. Green fluorescence of tBID-GFP exactly over-
lapped with COX VIc immunostaining in the early andsion level of tBID was much lower than that of its precur-
sor (data not shown). As shown in Figure 5C, much more late stages, further suggesting that tBID is targeted to
the mitochondria.BclxL was coimmunoprecipitated with tBID than with
full-length BID, and the difference was estimated around
20-fold by phosphoimager. It was reported that the pres- BclxL and Caspase Inhibitors Inhibit Distinct Steps
in Apoptosis Induced by Truncated BIDence of detergent in coimmunoprecipitation experi-
ments affects theconformation of Bax and its interaction To elucidate the mechanism of tBID-induced apoptosis,
we examined the effects of various cell death inhibitors,with Bcl2/BclxL (Hsu and Youle, 1997), so we examined
the interaction between BID and BclxL in the absence such as CrmA, p35, zVAD-fmk, Casp9 (C287A) dominant
negative mutant (DN), and BclxL, on tBID-induced mito-of detergent. The interaction between the full-length BID
and GST-BclxL in the absence of detergent was not chondrial damage, cell shrinkage, and nuclear conden-
sation. Ninety-eight percent of MCF7/Fas cells under-significantly different from the background, while the
tBID C-terminal fragment, but not the N-terminal frag- went cell shrinkage and nuclear condensation and
fragmentation at 4 hr after induction of tBID-GFP (Fig-ment, still bound effectively to BclxL (Figure 5D). Thus,
our in vivo and in vitro data indicate that the N-terminal ures 6A and 6B). Among caspase inhibitors, CrmA had
no effect, and p35 had a modest effect (32% inhibition),domain of BID may have an inhibitory function, and the
removal of the N-terminal domain exposes BID's BH3 while zVAD-fmk inhibited most of tBID-induced cell
shrinkage and nuclear condensation (90% inhibition)domain to allow efficient interactions with other pro-
teins. (Figures 6B and 6C), indicating that the caspase activity
is required for tBID-induced cell shrinkage and nuclear
condensation. Casp9 DN mutant also inhibited tBID-
Truncated BID Induces Mitochondrial Damage, induced cell shrinkage and nuclear condensation, but
Cell Shrinkage, and Nuclear Condensation was less effective than zVAD-fmk (71% inhibition) (Fig-
Mitochondrial damage and release of cytochrome c ure 6B), suggesting that BID acts upstream of Casp9/
have been identified as key events in mediating activa- cytochrome c/Apaf1 pathway. Thirty hours after induc-
tion of downstream caspases in apoptosis (Liu et al., tion, most of the cells remained normal in the presence
1996; Shimizuet al., 1996; Susin et al., 1996). Occurrence of zVAD-fmk (85%), while only 30% of nuclei were nor-
of these events is prevented by overexpression of Bcl2/ mal in the presence of Casp9 DN mutant (data not
BclxL (Kluck et al., 1997; Vander Heiden et al., 1997; shown), indicating that Casp9 DN mutant can only delay,
Yang et al., 1997). We postulated that tBID may be able not block, the apoptotic process induced by tBID. Com-
to mediate mitochondrial damage that is inhibitable by pared to other inhibitors, BclxL, which completely inhib-
BclxL. To illustrate the downstream events resulting from ited tBID-induced cell shrinkage and nuclear condensa-
the cleavage of BID, we used an ecdysone-inducible tion, was the most effective antagonist of tBID's function
system in which the tBID-GFP fusion gene was placed (Figures 6B and 6D).
under the control of an ecdysone-inducible promoter. Although zVAD-fmk, Casp9 DN, and BclxL have com-
After transient transfection of tBID-GFP and transactiva- parable effects on tBID-induced cell shrinkage and nu-
tor pVgRXR overnight, the expression of tBID-GFP was clear condensation, they had very different effects on
induced by addition of 1 mM of muristerone A, an ecdy- tBID-induced mitochondrial damage. As shown in Fig-
sone analog, and examined by appearance of green ure 6D, the distribution of mitotracker, cytochrome c,
fluorescence. Green fluorescence of tBID-GFP could be and COX VIc in tBID/BclxL±expressing cells was the
detected as early as 2 hr after induction (data not same as that in normal cells where green fluorescence
shown). Mitochondrial integrity was examined by fluo- of tBID-GFP overlapped with mitotracker signals and
rescent dye mitotracker, whose uptake depends on mi- immunostaining of cytochrome c and COX VIc. In con-
tochondrial membrane potential, immunostaining of cy- trast, in the presence of zVAD-fmk, the signal of mito-
tochrome c, which resides between inner and outer tracker disappeared from the peripheral region of cyto-
mitochondrial membranes, and cytochrome c oxidase plasm and became aggregated around the nuclei, while
subunit VIc (COX VIc), which resides within the inner immunostaining of cytochrome c completely disap-
mitochondrial membrane. The change of nuclear mor- peared (Figure 6C), suggesting that zVAD-fmk inhibits
phology was monitored by Hoechst dye staining. In the the loss of mitochondrial inner membrane potential but
early stage of tBID-induced apoptosis, when nuclear not the release of cytochrome c induced by tBID. The
morphology was largely normal, the signals of mito- Casp9 DN mutant has a similar but less effective inhibi-
tory activity (data not shown). As COX is an enzymetracker, immunostaining of cytochrome c, and COX VIc
Transducing Fas Signal by Casp8 Cleavage of BID
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Figure 6. Differential Effects of BclxL and zVAD-fmk on Truncated BID±Induced Apoptosis
(A) tBID-induced mitochondrial depolarization and the release of cytochrome c. MCF7/Fas cells were transfected with pIND-tBID-GFP and
pVgRxR overnight and induced with muristerone A for 4 hr. For mitotracker staining, 300 nM Mitotracker CMTMRos was added into medium
and then cells were fixed. For immunohistochemistry, cells were then fixed and immunostained with either anti-cytochrome c antibody or
anti-COX VIc antibody. Arrows indicate the cells expressing tBID-GFP fusion protein.
(B) Effects of different cell death inhibitors on tBID-induced nuclear condensation. pIND-tBID-GFP and pVgRxR were transfected into MCF7/
Fas or in combinations with different cell death inhibitors: CrmA, p35, Casp9 DN mutant, and BclxL. After overnight transfection, 1 mM of
muristerone A was added into medium (for zVAD-fmk, cells were incubated with 100 mM of zVAD-fmk for half an hour prior to the addition
of muristerone A). After 4 hr induction, cells were fixed and washed with PBS and then incubated with 1 ng/ml of Hoechst dye. Percentage
of nuclear condensation was scored by nuclear morphology.
(C) zVAD-fmk±inhibited tBID-induced loss of mitochondrial membrane potential, indicated by the ability of mitochondria to uptake mitotracker,
cell shrinkage, and nuclear condensation, but not mitochondrial clustering and cytochrome c release. Cells were incubated with 100 mM of
zVAD-fmk for half an hour prior to addition of muristerone A. Similar experiments described in (B) were performed. Arrows indicate the cells
expressing tBID-GFP fusion protein.
(D) BclxL completely inhibited all apoptotic morphological changes induced by tBID. BclxL construct was cotransfected into MCF7/Fas cells
along with pIND-tBID-GFP and pVgRxR. After overnight transfection, similar experiments described in (B) were performed. Arrows indicate
the cells expressing tBID-GFP fusion protein.
localized in the inner membrane of mitochondria, immu- Truncated BID Induces the Release
of Cytochrome c from Purifiednostaining of COX VIc is an indication of mitochondrial
distribution. In contrast to the disappearance of cyto- Mitochondria In Vitro
To examine the mechanismby which BID mediatesmito-chrome c immunostaining in the presence of zVAD-fmk,
the signal of COX VIc immunostaining remained largely chondrial damage, we evaluated its ability to induce
cytochrome c release from partially purified mitochon-clustered around nuclei and overlapped with the tBID-
GFP signal (Figure 6C). Taken together, these results dria in a cell-free system. Partially purifed mitochondria
were incubated with purified full-length BID or its trun-suggest that tBID induces the redistribution of mito-
chondria and the release of cytochrome c in a caspase- cated form, and the release of cytochrome c was exam-
ined. As shown in Figure 7, both full-length and tBIDindependent process but does not cause a complete
disruption of mitochondrial inner membrane in the pres- were able to induce the release of cytochrome c from
mitochondria, but tBID was much more efficient thanence of caspase inhibitors.
Cell
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induced BID translocation represents a novel mecha-
nism to release the proapoptotic potential of BID, per-
haps by removing the inhibitory N-terminal domain,
exposing BH3 domain and allowing tBID to interact with
its receptor on the mitochondria.
Availability of different cell death inhibitors allowed
Figure 7. Truncated BID Induced the Release of Cytochrome c from
us to map accurately the position of BID in the FasPartially Purified Mitochondria In Vitro
signaling pathway and to study the downstream events
Purified recombinant BID or tBID were incubated with partially puri-
after BID cleavage. The first detectable morphologicalfied mitochondria from mouse liver, and the released cytochrome
change induced by tBID is the clustering of mitochon-c was examined by immunoblotting.
dria around the nuclei at a stage when cytochrome c
appears to remain largely within the mitochondria and
full-length BID. This result is consistent with our in vivo mitotracker uptake is normal. Such movement of mito-
observation that tBID is more potent in its proapoptotic chondria has not been detected previously during the
activity than its precursor. Fas-induced apoptosis, which may be because of two
reasons. First, Fas-induced apoptosis can activate mul-
Discussion tiple apoptotic downstream events that occur very fast,
and thus it may be difficult to capture such an intermedi-
A number of BH3-containing death agonists of the Bcl2 ate step. Second, caspase inhibitors such as CrmA, p35,
family have been recently identified. Among them, a and zVAD-fmk are all effective inhibitors of Casp8, and
group of so-called ªBH3-onlyº death agonists, including thus they inhibit the activation of Casp8 itself and pre-
Bik/Bbk, BID, Hrk/DP5, and newly identified Blk and vent the activation of downstream events altogether.
Bim, seem to be more potent in their apoptosis-inducing Truncated BID allows us to bypass the requirement of
activity than other death agonists in the family that con- Casp8 to dissect the downstream events of the Fas
tains additional BH1 and BH2 domains such as Bad. pathway. Why do mitochondria appear to be clustering
Identification of C. elegans egl-1 as a general compo- around nuclei in the early stage of tBID-induced apopto-
nent of programmed cell death machinery indicates that sis? One possible explanation is that mitochondria are
BH3-containing death agonists are important regulators damaged sequentially, with mitochondria closest to the
in apoptosis (Conradt and Horvitz, 1998). The BH3 do- cytoplasmic membrane being damaged first. Alterna-
main is the only homologous region shared by these tively, tBID may be able to induce not only mitochondrial
BH3-only death agonists, indicating that they may use leakage but also their detachment from cytoskeletal
a common BH3 domain-mediated mechanism to induce structure, resulting in their collapsing around nuclei.
apoptosis, although the regulation of their activities may More experiments will be done to distinguish these two
be different from each other. BID differs from other BH3- possibilities.
only molecules by two characteristics: the absence of The second detectable morphological change in tBID-
a C-terminal hydrophobic membrane anchor, and the induced apoptosis appears to be the release of cyto-
presence of two perfect cleavage sites for Casp8 and chrome c while mitotracker uptake is still normal. In the
granzyme B, respectively, which are not found in other presence of zVAD-fmk,we can see rings of mitochondria
BH3-only molecules. Although overexpression of full- that are mitotracker-positive and COX VIc±positive,
length BID can induce apoptosis in certain cells (data while cytochrome c immunostaining has disappeared.
not shown; Wang et al., 1996), its truncated form is much Since cytochrome c resides between the inner and outer
more potent, indicating that caspase cleavage is one of mitochondrial space, mitotracker uptake depends upon
the mechanisms to regulate its proapoptotic activity. It mitochondrial membrane potential, and COX VIc resides
was recently reported that death antagonists of the Bcl2 in the inner mitochondrial membrane, our results sug-
family, such as CED-9, Bcl2, and BclxL, can be cleaved gest that tBID may be able to cause disruption of the
by caspases (Cheng et al., 1997; Xue and Horvitz, 1997; outer mitochondrial membrane directly, while the dis-
Clem et al., 1998), indicating that caspase cleavage of ruption of inner mitochondrial membrane needs the
Bcl2 family members is evolutionarily conserved and help from caspase. Our results are consistent with the
diversified. observation of Vander Heiden et al. (1997), who have
We presented the evidence of BID translocation from suggested that in apoptosis the disruption of outer mito-
cytosol to mitochondria during propagation of a death chondrial membrane occurs before the loss of mito-
signal. Such translocation during apoptosis has been chondrial membrane potential, which is mainly an indi-
observed for two additional members of the Bcl2 family, cation of the inner mitochondrial membrane integrity.
Bax and BAD. It was reported that Bax moves from Our results are also consistent with the observation of
cytosol to mitochondria during apoptosis, although the Bossy-Wetzel et al. (1998), who showed that the loss of
regulatory mechanism of Bax translocation is unclear mitochondrial membrane potential, but not cytochrome
(Wolter et al., 1997). BAD exhibits a similar behavior c release of CEM and HeLa cells induced by UVB irradia-
when FL5.12 cells are starved for IL-3 and the transloca- tion or staurosporine treatment, can be inhibited by
tion is regulated by protein phosphorylation (Zha et al., zVAD-fmk. We suggest that BID or related BH3 domain±
1996). Translocation from cytosol to mitochondria may containing proteins may be involved in inducing mito-
be an important activating mechanism for the proapo- chondrial damage in apoptosis induced by other stimuli
ptotic members of the Bcl2 family and the propagation as well, although the mechanism of activation may be
different.of apoptotic signals intracellularly. Caspase cleavage±
Transducing Fas Signal by Casp8 Cleavage of BID
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Although caspase inhibitors such as Casp9 DN, p35, and Bax and allowing such dimerization to occur. Inter-
and zVAD-fmk are unable to inhibit the early mitochon- estingly, while we can detect the interaction of full-
drial damages induced by tBID, they can inhibit the loss length BID with BclxL in the presence of detergent, such
of mitochondrial membrane potential, cell shrinkage, interaction appears to be largely absent in the absence
and nuclearcondensation induced by tBID with different of detergent. In contrast, the interaction of tBID with
effectiveness. While CrmA does not inhibit tBID-induced BclxL is still very strong in the absence of detergent. Our
cell death, and p35 has a modest effect, zVAD-fmk is results indicate that the interaction of tBID with BclxL is
very effective in inhibiting tBID-induced nuclear conden- not induced by detergent. On the other hand, nonionic
sation and in halting apoptotic process at an early stage detergent appears to enhance the binding of full-length
when mitochondria cluster around normal-looking nu- BID with BclxL, suggesting that detergent may be able
clei. The inhibitory activity of Casp9 DN mutant is similar to induce the conformational change of BID by removing
to that of zVAD-fmk but less effective. Although this the inhibition of N-terminal domain, a hypothesis that
spectrum of inhibitor profile does not allow us to identify can be examined directly by further experimentation.
positively thecritical caspase(s) involved in this process,
it does suggest, however, that the release of cytochrome Experimental Procedures
c may not be the only critical event downstream from
Construction of Mouse Spleen cDNA Small Poolthe mitochondrial damage induced by tBID, since Casp9
Library and In Vitro Expression CloningDN is only partially effective in inhibition of tBID-induced
A mouse spleen cDNA library of 2 3 105 independent clones wascell death. This conclusion is also supported by the fact
constructed by using a Stratagene cDNA synthesis and cloning kit
that tBID induces apoptosis of MCF7/Fas cells effec- (Stratagene, La Jolla, CA), and cDNAs were inserted into EcoRI and
tively, while microinjection of cytochrome c to MCF7/ XhoI sites of pCS2. Pools of cDNAs and in vitro translations were
Fas cells does not induce apoptosis (Li et al., 1997a). done as described by Lustig et al. (1997). The caspase cleavage
assay was performed as described previously (Li et al., 1997b).Alternatively, tBID may activate downstream caspases
The individual positive cDNA was identified using 96-well plates asby a cytochrome c±independent pathway in which tBID
described (Lustig et al., 1997), was sequenced, and compared withsimply competes BclxL from BclxL/Apaf1/caspase com-
known sequences by searching the GenBank database.plex and activates downstream caspases. The observa-
tion that the Apaf1/Casp9/BclxL complex exists (Hu et Bacterial and Mammalian Expression Constructs of Murine
al., 1998; Pan et al., 1998) provides additional support and Human Bid and Generation of Anti-BID Antibody
for this model. These two mechanisms, however, are The original clone of murine Bid obtained from the small pool library
contained the full-length open reading frame of Bid. The standardnot mutually exclusive, and the mechanism by which
molecular cloning methods and PCR were used to construct varioustBID acts may be cell type±specific.
mammalian expression vectors of murine Bid.In contrast to caspase inhibitors, BclxL can fully block The full-length human BID gene was amplified by PCR from EST
the tBID's activity. Thus, the interaction of tBID with cDNA clone 52055 (Research Genetics, Inc., Huntsville, AL) and then
BclxL must be the key to its ability to induce apoptosis. cloned into the BamHI site of pGEX-2T. GST-BID fusion protein was
Kelakar et al. (1997) reported recently that wild-type purified by GST beads, GST was removed by thrombin digestion,
BAD fails to induce apoptosis in response to growth and the purified BID protein was injected into rats to generate poly-
clonal antibody.factor withdrawal when cells are protected by a BclxL
To establish an inducible expression system of tBid, tBid wasmutant that does not bind to the BAD BH3 domain,
inserted into BamHI site in frame with GFP (green fluorescencesuggesting that the interaction between the BH3 domain
protein) in pEGFP-N1 vector (CLONTECH, Palo Atlo, CA), generatingand Bcl2/BclxL is critical for BH3 domain's proapoptotic tBID-GFP fusion gene. The cassette of tBID-GFP was then cloned
activity. tBID may behave as an intracellular ligand for into EcoRI and NotI sites of pIND (Invitrogen, San Diego, CA).
BclxL, which acts as the receptor in the Fas pathway.
Unlike the conventional ligand±receptor interactions at Site-Directed Mutagenesis of the Cleavage Sites of Bid
Aspartic acid residues at positions 59 and 75 of Bid were mutatedcytoplasmic membrane, where such interactions usually
to glutamic acid individually or in combination, using QuickChangeresult in the activation of the receptor, the interaction
site-directed mutagenesis kit (Stratagene), following the supplier'sof tBID with BclxL results in the inactivation of protective instruction. Mutated sites were verified by DNA sequencing.
functions of BclxL (or may we call it the activation of
apoptotic-inducing functions of BclxL?). Alternatively, Tissue Culture Cells
tBID may be capable of triggering apoptosis on its own, Jurkat cells were cultured in RPMI 1640 supplemented with 10%
which may be Bcl2/BclxL±inhibitable, or Bcl2/BclxL may fetal bovine serum (FBS), and HeLa and HEK 293T cells were cul-
tured in DMEM containing 10% FBS. MCF7/Fas and MCF7/Fas/simply act as a neutralizer of its death-inducing activity.
BclxL stable cells were cultured in RPMI 1640 containing 10% FBS,These are interesting questions for future experiments.
200 mg/ml G418, and 100 mg/ml hygromycin (Srinivasan et al., 1998).The dimeric interactions of antiapoptotic members of
the Bcl2 family with proapoptotic members of the Bcl2 Immunohistochemistry
have been hypothesized to be an important mechanism For Mitotracker staining, Mitotracker CMTMRos (Molecular Probes
of regulation (Oltvai and Korsmeyer, 1994). Recently, Inc., Eugene, OR) was added to medium in a final concentration of
however, this view has been questioned mainly because 300 nM, and cells were further cultured for 30 min and fixed in 4%
paraformadehyde for 15 min. Immunohistochemistry of cytochromeof two works. First, Knudson and Korsmeyer (1997) re-
c and COX VIc was done according to Srinivasan et al. (1998), withported that, in a genetic analysis, Bcl2 and Bax are able
minor modifications.to act independently. Second, Hsu and Youle (1997)
reported that the dimeric interaction of Bcl2 and Bax In Vitro and In Vivo Binding Assays
can only be detected in the presence of detergent, sug- 35S-labeled BID or its cleaved form was incubated with 10 mg GST-
gesting that detergent may induce specific conforma- BclxL in 100 ml of the binding buffer (10 mM HEPES [pH 7.5], 150
mM KCl, 5 mM MgCl2, 1 mM EDTA, and 0.25% IGEPAL CA-630) attional changes, exposing the interacting domain of Bcl2
Cell
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48C for 3 hr with agitation. After brief centrifugation, beads were Cryns, V., and Yuan, J. (1998). Proteases to die for. Genes Dev. 12,
1551±1570.washed three times with 400 ml of binding buffer and resuspended
in protein sample buffer. The samples were subjected to SDS-PAGE Fernandes-Alnemri, T., Armstrong, R.C., Krebs, J., Srinivasula, S.M.,
and autoradiography. Wang, L., Bullrich, F., Fritz, L.C., Trapani, J.A., Tomaselli, K.J., Lit-
For in vivo binding assay, constructs expressing BID-Flag or tBID- wack, G., et al. (1996). In vitro activation of CPP32 and Mch3 by
Flag fusion protein were cotransfected with the construct express- Mch4, a novel human apoptotic cysteine protease containing two
ing BclxL into HEK 293T cells by a calcium-phosphate method. After FADD-like domains. Proc. Natl. Acad. Sci. USA 93, 7464±7469.
24 hr, cells were lysed in 1 ml of binding buffer, and total cell lysates Hsu, Y.-T., and Youle, R.J. (1997). Nonionic detergents induces di-
were centrifuged at 10,000 3 g for 15 min. M2 anti-Flag affinity gel merization among members of the Bcl-2 family. J. Biol. Chem. 272,
(30 ml) was added into the supernatant, and the resulting mixture 13829±13834.
was incubated at 48C for 3 hr with agitation. Following three washes,
Hu, Y., Benedict, M.A., Wu, D., Inohara, N., and Nunez, G. (1998). Bcl-the beads were resuspended in appropriate amounts of protein
xL interacts with Apaf-1 and inhibits Apaf-1-dependent caspase-9sample buffer. The samples were subjected to Western blotting
activation. Proc. Natl. Acad. Sci. USA 95, 4386±4391.analysis.
Huang, D.C.S., Adams, J.M., and Cory, S. (1998). The conserved
N-terminal BH4 domain of Bcl-2 homologues is essential for inhibi-Cell-Free Assay for the Release of Cytochrome c
tion of apoptosis and interaction with CED-4. EMBO J. 17, 1029±from Purified Mouse Liver Mitochondria
1039.Mitochondria were purified as described by Shimizu et al. (1998).
For in vitro assay, 5 ml of purified mitochondria was incubated with Kelekar, A., Chang, B.S., Harlan, J.E., and Thompson, C.B. (1997).
purified BID or tBID at 378C for 1 hr. The reaction mixture was then Bad is a BH3 domain±containing protein that forms an inactivating
centrifuged at 10,000 3 g for 10 min, and the supernatant was dimer with Bcl-XL. Mol. Cell. Biol. 17, 7040±7046.
subjected to SDS-PAGE and immunoblotting using anti-cytochrome Kischkel, F.C., Hellbardt, S., Behrmann, I., Germer, M., Pawlita, M.,
c antibody. Krammer, P.H., and Peter, M.E. (1995). Cytotoxicity-dependent
APO-1 (Fas/CD95)-associated proteins form a death-inducing sig-
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